NO20034414L - Anvendelse av N-fenyl-2-pyrimidinaminderivater mot mastcellebaserte sykdommer slik som allergiske forstyrrelser - Google Patents

Anvendelse av N-fenyl-2-pyrimidinaminderivater mot mastcellebaserte sykdommer slik som allergiske forstyrrelser

Info

Publication number
NO20034414L
NO20034414L NO20034414A NO20034414A NO20034414L NO 20034414 L NO20034414 L NO 20034414L NO 20034414 A NO20034414 A NO 20034414A NO 20034414 A NO20034414 A NO 20034414A NO 20034414 L NO20034414 L NO 20034414L
Authority
NO
Norway
Prior art keywords
phenyl
mast cell
allergic disorders
based diseases
derivatives against
Prior art date
Application number
NO20034414A
Other languages
English (en)
Other versions
NO325454B1 (no
NO20034414D0 (no
Inventor
Kenichi Koike
Atsushi Komiyama
Kovichi Takeuchi
Original Assignee
Us Gov Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Veterans Affairs filed Critical Us Gov Veterans Affairs
Publication of NO20034414D0 publication Critical patent/NO20034414D0/no
Publication of NO20034414L publication Critical patent/NO20034414L/no
Publication of NO325454B1 publication Critical patent/NO325454B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20034414A 2001-04-05 2003-10-02 Anvendelse av N-{5-[4-(4-metyl-piperazino-metyl)-benzoylamido]-2-metylfenyl}-4-(3-pyridyl)-2-pyrimidin-amin. NO325454B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108606.5A GB0108606D0 (en) 2001-04-05 2001-04-05 Organic compounds
PCT/US2002/010742 WO2002080925A1 (en) 2001-04-05 2002-04-05 Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders

Publications (3)

Publication Number Publication Date
NO20034414D0 NO20034414D0 (no) 2003-10-02
NO20034414L true NO20034414L (no) 2003-12-04
NO325454B1 NO325454B1 (no) 2008-05-05

Family

ID=9912339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034414A NO325454B1 (no) 2001-04-05 2003-10-02 Anvendelse av N-{5-[4-(4-metyl-piperazino-metyl)-benzoylamido]-2-metylfenyl}-4-(3-pyridyl)-2-pyrimidin-amin.

Country Status (18)

Country Link
EP (1) EP1389113A1 (no)
KR (2) KR20090034998A (no)
CN (1) CN1529602A (no)
AU (1) AU2002307140B2 (no)
BR (1) BR0208663A (no)
CA (1) CA2443092A1 (no)
CZ (1) CZ20032705A3 (no)
GB (1) GB0108606D0 (no)
HU (1) HUP0303751A3 (no)
IL (1) IL158061A0 (no)
MX (1) MXPA03009058A (no)
NO (1) NO325454B1 (no)
NZ (1) NZ528934A (no)
PL (1) PL363080A1 (no)
RU (1) RU2304436C2 (no)
SK (1) SK12312003A3 (no)
WO (1) WO2002080925A1 (no)
ZA (1) ZA200307563B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE343415T1 (de) 2001-06-29 2006-11-15 Ab Science Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
JP2005500041A (ja) 2001-06-29 2005-01-06 アブ サイエンス 強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤
DK1401413T3 (da) 2001-06-29 2007-03-26 Ab Science Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme
JP2004537537A (ja) 2001-06-29 2004-12-16 アブ サイエンス 炎症性疾患を治療するためのチロシンキナーゼ阻害剤の使用法
GB0201882D0 (en) * 2002-01-28 2002-03-13 Novartis Ag Organic compounds
AU2003226209B2 (en) * 2002-03-21 2008-10-23 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
CN100491374C (zh) 2002-08-02 2009-05-27 Ab科学公司 2-(3-氨基芳基)氨基-4-芳基-噻唑及其作为c-kit抑制剂的应用
WO2004076693A1 (en) * 2003-02-27 2004-09-10 Ab Science Tailored treatment suitable for different forms of mastocytosis
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
TWI324604B (en) 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
CA2578122A1 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives
JP5129123B2 (ja) * 2005-05-02 2013-01-23 ノバルティス アーゲー 全身性肥満細胞症の処置のためのピリミジルアミノベンズアミド誘導体の使用
KR100845278B1 (ko) * 2006-08-04 2008-07-09 포항공과대학교 산학협력단 비만 세포의 활성을 유도하는 펩타이드 및 이를 포함하는면역조절제
CN102421430B (zh) * 2009-04-06 2014-06-25 纽若泰克制药株式会社 用于预防或治疗烧伤的药物组合物
CN103058935B (zh) * 2013-01-15 2015-05-06 四川大学 一种嘧啶类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso

Also Published As

Publication number Publication date
GB0108606D0 (en) 2001-05-23
NO325454B1 (no) 2008-05-05
HUP0303751A3 (en) 2005-06-28
CN1529602A (zh) 2004-09-15
WO2002080925A1 (en) 2002-10-17
MXPA03009058A (es) 2004-11-22
HUP0303751A2 (hu) 2005-04-28
CA2443092A1 (en) 2002-10-17
KR20090034998A (ko) 2009-04-08
BR0208663A (pt) 2004-03-09
IL158061A0 (en) 2004-03-28
PL363080A1 (en) 2004-11-15
SK12312003A3 (sk) 2004-02-03
AU2002307140B2 (en) 2006-02-16
RU2003130635A (ru) 2005-02-10
NZ528934A (en) 2006-10-27
NO20034414D0 (no) 2003-10-02
ZA200307563B (en) 2004-04-21
RU2304436C2 (ru) 2007-08-20
EP1389113A1 (en) 2004-02-18
CZ20032705A3 (en) 2004-06-16
KR20040007485A (ko) 2004-01-24

Similar Documents

Publication Publication Date Title
NO20034414D0 (no) Anvendelse av N-fenyl-2-pyrimidinaminderivater mot mastcellebaserte sykdommer slik som allergiske forstyrrelser
NO20043158L (no) Substituerte kinazolinderivater som inhibitorer av aurorakinaser
NO20034523L (no) Pyrazolderivater for behandling av HIV
NO20042288L (no) Kinazolinderivater som antitumormidler
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20035193L (no) Nye pyrrolderivater som farmas degree ytiske midler
EE200300359A (et) Asendatud asaindooloksoatseetpiperasiini derivaatide koostis ja viirusevastane toime
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DK1453517T3 (da) Farmaceutiske formuleringer med platinderivat
NO20042112L (no) Anvendelse av glycosider av mono- og diacylglycerol som anti-inflammatoriske midler.
DE60218175D1 (de) Stabilisierte orale suspensionsformulierung
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20044916L (no) Preparater av sulfinylacetamid
AU2003255982A1 (en) Preparation of microcapsules
NO20041968L (no) Anvendelse av cystationin
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
AU2003209647A1 (en) Optical measurements of patterned structures
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20043084L (no) 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA
NO20043948L (no) Fremstilling av olefiner
EE200300570A (et) Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
ITMI20041199A1 (it) Composizioni di coloranti e loro utilizzo

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees